We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
-10.31%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$210M
AUM Growth
-$127M
Cap. Flow
-$94.5M
Cap. Flow %
-45.09%
Top 10 Hldgs %
33.75%
Holding
46
New
–
Increased
–
Reduced
33
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.57M
2
PFE icon
Pfizer
PFE
+$4.61M
3
AEP icon
American Electric Power
AEP
+$4.15M
4
UNH icon
UnitedHealth
UNH
+$4.13M
5
DUK icon
Duke Energy
DUK
+$4.05M

Sector Composition

Rank Sector Weight
1 Healthcare 30.09%
2 Technology 13.81%
3 Financials 11.26%
4 Utilities 9.76%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$223B
$5.09M 2.43%
22,745
-14,195
-38% -$3.33M
JNJ icon
27
Johnson & Johnson
JNJ
$629B
$4.91M 2.34%
38,015
-20,500
-35% -$2.86M
BNY
28
Bank of New York Mellon
BNY
$111B
$4.79M 2.29%
101,845
-38,525
-27% -$1.87M
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
$4.64M 2.21%
47,620
-20,015
-30% -$2.37M
EOG icon
30
EOG Resources
EOG
$75.1B
$4.6M 2.19%
52,710
-12,210
-19% -$1.31M
CELG
31
DELISTED
Celgene Corp
CELG
$4.48M 2.14%
69,903
-15,790
-18% -$1.17M
CVX icon
32
Chevron
CVX
$386B
$4.39M 2.1%
40,400
-15,775
-28% -$1.83M
KMI icon
33
Kinder Morgan
KMI
$70.7B
$4M 1.91%
259,850
-127,315
-33% -$2.16M
KO icon
34
Coca-Cola
KO
$373B
$1.16M 0.55%
24,400
– –
FE icon
35
FirstEnergy
FE
$27.2B
$1.08M 0.52%
28,900
– –
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$1M 0.48%
19,300
– –
IFF icon
37
International Flavors & Fragrances
IFF
$21.4B
$967K 0.46%
7,200
– –
DE icon
38
Deere & Co
DE
$167B
$940K 0.45%
6,300
– –
COST icon
39
Costco
COST
$421B
$876K 0.42%
4,300
– –
ADP icon
40
Automatic Data Processing
ADP
$107B
$865K 0.41%
6,600
– –
MAR icon
41
Marriott International
MAR
$92.5B
$771K 0.37%
7,100
– –
A icon
42
Agilent Technologies
A
$41.9B
$742K 0.35%
11,000
– –
AAPL icon
43
Apple
AAPL
$4.41T
$694K 0.33%
17,600
– –
ZBH icon
44
Zimmer Biomet
ZBH
$18.7B
$622K 0.3%
6,180
– –
GILD icon
45
Gilead Sciences
GILD
$168B
$588K 0.28%
9,400
– –
NVDA icon
46
NVIDIA
NVDA
$5.43T
$454K 0.22%
136,000
– –
1
2

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Stralem & Co held 46 positions worth $210M, down 38% from $337M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Stralem & Co withdrew a net $94.5M in Q4 2018, reducing 33 holdings. Its largest reduction was Merck, cutting an estimated $5.57M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Stralem & Co's biggest Q4 2018 reduction was Merck, cutting an estimated $5.57M.
  • Stralem & Co's ten largest holdings make up 34% of its $210M portfolio in Q4 2018.
  • Stralem & Co opened 0 new positions and closed 0 in Q4 2018.
  • Stralem & Co's portfolio value fell 38% quarter-over-quarter to $210M.

Based on Stralem & Co's 13F filing for Q4 2018, filed 18 Jan 2019.